Company Analysis
Sign in

Abbvie Inc. (ABBV)

NYSE: ABBV · Pharmaceutical Preparations · North Chicago, IL · filing with the SEC since 2012
Full chart Alerts Compare
Grade6.3
◀ Past 8.0● Present 6.1▶ Future 4.7
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

4,418 patents granted to the 93 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Abbvie Inc.’s names, not what it holds today.

Patents granted
4,418
4,307 utility, 99 design, 12 reissue, 1976 to Dec 31, 2025
Granted in 2025
28
Against 55 in 2024 and 56 in 2023
Applications published
5,833
196 of them in 2025
Names they are printed under
93
a subsidiary, its own name
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals166
Medical technology63
Organic fine chemistry37
Biotechnology21
Handling4
Analysis of biological materials3
Chemical engineering2
Audio-visual technology1
Macromolecular chemistry, polymers1
Materials, metallurgy1
IT methods for management1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name93 counted
Allergan, Inc. a subsidiary
US, as the owner printed on each patent. 11 more under the same name are not counted (printed in IE)
2,291 granted
1,761 published
AbbVie Inc. its own name
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in IL)
819 granted
450 published
Allergan, Inc. a subsidiary
named as the applicant on its applications, in US. 1 more under the same name are not counted (printed in CA)
0 granted
879 published
AbbVie Inc. its own name
named as the applicant on its applications, in US. 7 more under the same name are not counted (printed in NL)
0 granted
746 published
IMMUNOGEN, INC. a subsidiary
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in GB)
256 granted
170 published
Pharmacyclics LLC a subsidiary
US, as the owner printed on each patent
198 granted
158 published
LifeCell Corporation a subsidiary
US, as the owner printed on each patent
153 granted
67 published
LifeCell Corporation a subsidiary
named as the applicant on its applications, in US
0 granted
188 published
ImmunoGen, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
182 published
Pharmacyclics LLC a subsidiary
named as the applicant on its applications, in US
0 granted
172 published
AbbVie Biotechnology Ltd. a subsidiary
BM, as the owner printed on each patent
93 granted
26 published
AbbVie Biotechnology Ltd. a subsidiary
named as the applicant on its applications, in BM. 2 more under the same name are not counted (printed in US)
0 granted
103 published
Zeltiq Aesthetics, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
90 published
ABBVIE STEMCENTRX LLC a subsidiary
US, as the owner printed on each patent
40 granted
47 published
Abb Vie Deutschland GmbH & Co. KG a subsidiary
DE, as the owner printed on each patent
78 granted
8 published
Zeltiq Aesthetics, Inc. a subsidiary
US, as the owner printed on each patent
57 granted
20 published
AbbVie Deutschland GmbH & Co. KG a subsidiary
named as the applicant on its applications, in DE
0 granted
74 published
AbbVie Biotherapeutics Inc. a subsidiary
US, as the owner printed on each patent
53 granted
14 published
Allergan Industrie, SAS a subsidiary
FR, as the owner printed on each patent
47 granted
15 published
Allergan Pharmaceuticals International Limited a subsidiary
named as the applicant on its applications, in IE
0 granted
61 published
Allergan Industrie, SAS a subsidiary
named as the applicant on its applications, in FR
0 granted
57 published
AbbVie Biotherapeutics Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
56 published
REPROS THERAPEUTICS INC. a subsidiary
US, as the owner printed on each patent
22 granted
33 published
Vicuron Pharmaceuticals Inc. a subsidiary
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in AT)
22 granted
25 published
Topokine Therapeutics, Inc. a subsidiary
US, as the owner printed on each patent
21 granted
24 published
Chase Pharmaceuticals Corporation a subsidiary
US, as the owner printed on each patent
15 granted
22 published
Allergan Pharmaceuticals International Limited a subsidiary
IE, as the owner printed on each patent
32 granted
3 published
ENVY MEDICAL, INC. a subsidiary
US, as the owner printed on each patent
25 granted
9 published
Aeropharm Technology, Inc. a subsidiary
US, as the owner printed on each patent
30 granted
0 published
Anterios, Inc. a subsidiary
US, as the owner printed on each patent
9 granted
17 published
UNIMED PHARMACEUTICALS INC. a subsidiary
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in KR)
15 granted
9 published
Knoll Pharmaceutical Company a subsidiary
US, as the owner printed on each patent
21 granted
2 published
MPEX Pharmaceuticals, Inc. a subsidiary
US, as the owner printed on each patent
9 granted
14 published
Gilgamesh Pharmaceuticals, Inc. a subsidiary
US, as the owner printed on each patent
5 granted
16 published
NAUREX, INC. a subsidiary
named as the applicant on its applications, in US
0 granted
20 published
Transderm, Inc. a subsidiary
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in KR)
8 granted
12 published
ForSight Vision5, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
18 published
Fournier Laboratories Ireland Limited a subsidiary
IE, as the owner printed on each patent. 1 more under the same name are not counted (printed in IL)
6 granted
12 published
KELLER MEDICAL, INC. a subsidiary
US, as the owner printed on each patent
12 granted
5 published
AKARNA THERAPEUTICS, LTD. a subsidiary
named as the applicant on its applications, in GB
0 granted
16 published
Tobira Therapeutics, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
16 published
Bonti, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
15 published
Tobira Therapeutics, Inc. a subsidiary
US, as the owner printed on each patent
8 granted
7 published
IEP Pharmaceutical Devices Inc. a subsidiary
US, as the owner printed on each patent
13 granted
0 published
KELLER MEDICAL, INC. a subsidiary
named as the applicant on its applications, in US
0 granted
13 published
Allergan Holdings France S.A.S. a subsidiary
named as the applicant on its applications, in FR
0 granted
12 published
Envy Medical, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
12 published
ForSight Vision5, Inc. a subsidiary
US, as the owner printed on each patent
10 granted
2 published
Mitokinin, Inc. a subsidiary
US, as the owner printed on each patent
5 granted
7 published
Allergan Holdings Unlimited Company a subsidiary
named as the applicant on its applications, in IE
0 granted
11 published
Anterios, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
10 published
Aptalis Pharma Canada Inc. a subsidiary
CA, as the owner printed on each patent
3 granted
5 published
CAPSTAN THERAPEUTICS, INC. a subsidiary
named as the applicant on its applications, in US
0 granted
8 published
NAUREX INC. a subsidiary
US, as the owner printed on each patent
4 granted
4 published
ABBVIE PHARMACEUTICALS GMBH a subsidiary
named as the applicant on its applications, in DE
0 granted
7 published
Elastagen Pty Ltd a subsidiary
named as the applicant on its applications, in AU
0 granted
7 published
Mitokinin, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
7 published
Transderm, Inc. a subsidiary
named as the applicant on its applications, in US. 1 more under the same name are not counted (printed in KR)
0 granted
7 published
ALLERGAN HOLDINGS FRANCE S.A.S. a subsidiary
FR, as the owner printed on each patent
6 granted
0 published
Akarna Therapeutics, Ltd. a subsidiary
GB, as the owner printed on each patent. 3 more under the same name are not counted (printed in CH, printed in US, printed in TW)
4 granted
2 published
Chase Pharmaceuticals Corporation a subsidiary
named as the applicant on its applications, in US
0 granted
6 published
Elastagen Pty Ltd a subsidiary
AU, as the owner printed on each patent
2 granted
4 published
FURIEX PHARMACEUTICALS, INC. a subsidiary
US, as the owner printed on each patent
4 granted
2 published
Hurricane, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
6 published
REPROS THERAPEUTICS INC. a subsidiary
named as the applicant on its applications, in US
0 granted
6 published
TeneoOne, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
6 published
Topokine Therapeutics, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
6 published
ABBVIE STEMCENTRX LLC a subsidiary
named as the applicant on its applications, in US
0 granted
5 published
Rowell Laboratories a subsidiary
US, as the owner printed on each patent
5 granted
0 published
TENEOONE, INC. a subsidiary
US, as the owner printed on each patent
3 granted
2 published
Gilgamesh Pharmaceuticals, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
4 published
Hurricane, Inc. a subsidiary
US, as the owner printed on each patent
4 granted
0 published
AbbVie Global Enterprises Ltd. a subsidiary
BM, as the owner printed on each patent
1 granted
2 published
Capstan Therapeutics, Inc. a subsidiary
US, as the owner printed on each patent
1 granted
2 published
DJS Antibodies Ltd a subsidiary
named as the applicant on its applications, in GB
0 granted
3 published
Furiex Pharmaceuticals, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
3 published
MARBELLE THREADS LTD. a subsidiary
named as the applicant on its applications, in IL
0 granted
3 published
Mavupharma, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
3 published
Unimed Pharmaceuticals, LLC a subsidiary
named as the applicant on its applications, in US. 1 more under the same name are not counted (printed in KR)
0 granted
3 published
ALLERGAN GI CORP. a subsidiary
named as the applicant on its applications, in US
0 granted
2 published
APTALIS PHARMA CANADA ULC a subsidiary
CA, as the owner printed on each patent
2 granted
0 published
APTALIS PHARMA S.R.L. a subsidiary
IT, as the owner printed on each patent
2 granted
0 published
AbbVie Global Enterprises Ltd. a subsidiary
named as the applicant on its applications, in BM
0 granted
2 published
Aliada Therapeutics, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
2 published
Aptalis Pharma US, Inc. a subsidiary
US, as the owner printed on each patent
1 granted
1 published
Bonti, Inc. a subsidiary
US, as the owner printed on each patent
1 granted
1 published
Pharmacyclics, Inc. A Delaware corporation a subsidiary
US, as the owner printed on each patent
0 granted
2 published
ABBVIE PHARMACEUTICALS GMBH a subsidiary
DE, as the owner printed on each patent
1 granted
0 published
APTALIS PHARMA CANADA ULC a subsidiary
named as the applicant on its applications, in CA
0 granted
1 published
AbbVie Manufacturing Management Unlimited Company a subsidiary
IE, as the owner printed on each patent
1 granted
0 published
FASTOX PHARMA SA a subsidiary
named as the applicant on its applications, in CH
0 granted
1 published
ImmunoGen Switzerland GmbH a subsidiary
named as the applicant on its applications, in CH
0 granted
1 published
Vicuron Pharmaceuticals, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
1 published
Names not counted (11)
Knoll LLC
Also listed as a subsidiary by MILLERKNOLL, INC.. 345 granted and 29 published under it are not counted.
Warner Chilcott Limited
Most of its patents print US; this name counts in BM. 40 granted and 35 published under it are not counted.
Knoll LLC
Also listed as a subsidiary by MILLERKNOLL, INC.. 0 granted and 52 published under it are not counted.
Aptalis Pharma S.r.l.
Most of its patents print IE; this name counts in IT. 10 granted and 9 published under it are not counted.
AbbVie Inc.
Most of its patents print NL; this name counts in US. 13 granted and 3 published under it are not counted.
Warner Chilcott Limited
Most of its patents print US; this name counts in BM. 0 granted and 12 published under it are not counted.
Aptalis Pharma S.r.l.
Most of its patents print IE; this name counts in IT. 0 granted and 11 published under it are not counted.
LifeCell Corporation
No country is printed for it. 0 granted and 2 published under it are not counted.
Syndesi Therapeutics SA
Most of its patents print US; this name counts in BE. 0 granted and 2 published under it are not counted.
LifeCell Corporation
No country is printed for it. 0 granted and 1 published under it are not counted.
Pacific Pharma, Inc.
Only generic words.
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 23, 202512,502,526Delivery of electromagnetic charge to musclesMedical technologyZeltiq Aesthetics, Inc.
Dec 23, 202512,502,420Clostridium botulinum serotype A neurotoxin (BoNT/A) sequence variantsBiotechnologyAbbVie Inc.
Dec 16, 202512,497,452Anti-hemojuvelin (HJV) antibodies for treating myelofibrosisPharmaceuticalsAbbVie Inc.
Nov 25, 202512,478,689Anti-CD19 antibody drug conjugatesPharmaceuticalsAbbVie Biotherapeutics Inc.
Nov 11, 202512,465,598Methods of treating migrainePharmaceuticalsAllergan Pharmaceuticals International Limited
Oct 14, 202512,440,530Skin solution with solubilized bakuchiolPharmaceuticalsENVY MEDICAL, INC.
Oct 7, 202512,433,951Methods of treatment of non-small-cell lung carcinoma using telisotuzumab vedotinPharmaceuticalsAbbVie Manufacturing Management Unlimited Company
Sep 16, 202512,415,085Phase adjusted coil excitation for muscle stimulationMedical technologyZeltiq Aesthetics, Inc.
Sep 9, 202512,409,211Non-protein Clostridial toxin compositionsPharmaceuticalsAllergan, Inc.
Aug 19, 2025D1,088,860PackagingLifeCell Corporation
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 25, 20252025/0387535TISSUE MATRICES WITH CONTROLLED POROSITY OR MECHANICAL PROPERTIESMedical technologyLifeCell Corporation
Dec 25, 20252025/0387325FIXED DOSE COMBINATION OF BRIMONIDINE AND TIMOLOLPharmaceuticalsAllergan, Inc.
Dec 25, 20252025/0387218SILICONE BREAST IMPLANT DELIVERYMedical technologyKELLER MEDICAL, INC.
Dec 18, 20252025/0382307IMPROVED METHODS FOR PREPARING N-METHYL ALANINE ESTERS OF MAYTANSINOLOrganic fine chemistryImmunoGen, Inc.
Dec 18, 20252025/0381188METHODS OF TREATING AND PREVENTING ALLOANTIBODY DRIVEN CHRONIC GRAFT VERSUS HOST DISEASEPharmaceuticalsPharmacyclics LLC
Dec 11, 20252025/0375575WEARABLE AUTOMATIC INJECTION SYSTEM AND APPARATUSMedical technologyAbbVie Inc.
Dec 11, 20252025/0375570INTRAOCULAR IMPLANT DELIVERY APPARATUS AND METHODS OF USE THEREOFMedical technologyAllergan, Inc.
Dec 11, 20252025/0375423PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETHYL]-3H-IMIDAZOLE DERIVATIVES FOR TREATING RETINAL DISEASESPharmaceuticalsAllergan, Inc.
Dec 4, 20252025/0368603PROCESS OF MAKING APOPTOSIS-INDUCING AGENTSOrganic fine chemistryAbbVie Inc.
Nov 20, 20252025/0352224SKIN TREATMENT SYSTEM WITH ADJUSTABLE HEIGHT WANDMedical technologyENVY MEDICAL, INC.
What it applied for, 2024 to 2025: Pharmaceuticals 225 · Medical technology 106 · Organic fine chemistry 45 · Biotechnology 15 · Macromolecular chemistry, polymers 4 · Audio-visual technology 3.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton ABBV · research, not advice